At VIROLAB, We Address the Global
Problem of Viral
Infections with Innovative Solutions
Development
of
THERAPEUTIC VACCINES
Against
Cancerous Lesions
Commitment to Global Health
VIROLAB is a Mexican genetic engineering and biotechnology startup company with two technological innovations that offer a solution to the global problem caused by human papillomavirus (HPV) infection.
Founded on December 23, 2005, VIROLAB has 25 years of experience in molecular biology and vaccine development around the world. It has conducted research and development of therapeutic vaccines against cancer. Clinical trials Phase I, II, III and IV completed and more than 10 years of follow-up in many patients.
THERAPEUTIC VACCINES
VACCINIA VIRUS THE MOST POWERFUL TOOLS TO
ELIMINATE CANCER
10K
Patients treated
14
Published research
3
Vaccines in development
